World News Insights
1-3 Minute Gist

Direct From the Editor / On Topics Vital to the Nation

How China's import cuts importing 8.5 million barrels a day down from 12.5 million and it's large oil reserve will keep oil prices low

07/15/2026

Not covered in the media for Hormuz is the combined response of US, China, India, Japan and the European Union to find alternatives to Hormuz making it less or not relevant to oil prices and oil supplies

07/10/2026

The Constructive Aspects of the situation in July 2026 from the Hormuz Crisis not covered in the Media

06/27/2026

Browse Articles or use Lyrarc's US patented "Groups" and "Links" for new insights. A Lyrarc Group of Articles on a topic gives insights into particular angles shown in the Group Title. A Lyrarc Link shows more specific insights for 2 articles.

All Topics Articles

LyrArc brings in selected articles from many of the world's top publications.

Articles are selected by experts and you can see the gist of the important articles.

Group of 20 Meets in a Mexico Outperforming Brazil

8 Groups   
New York Times - 06.17.2012 Original article ›
Elisabeth Malkin, Elisabeth, Malkin, Simon Romero, Simon, Romero
LyrArc Article Gist
Mexico's GDP increases at 3.9% compared to 2.7% for Brazil in 2011. Foreign investment is increasing in Mexico especially in the automobile industry and in industries where Mexico is favored over China as a production location. The G-20 meets in Los Cabos, Mexico in June 2012.
Read LyrArc gist ›

How Mexico Got Back in the Game

14 Groups   
New York Times - 02.23.2013 Original article ›
Thomas L. Friedman, Thomas, L., Friedman
LyrArc Article Gist
The increasing competitiveness of Mexico compared to China and India as an investment destination in 2013. Foreign companies are investing heavily in Mexico because of investment advantages in labor cost, supply of engineering and management talent, and proximity to the U.S.
Read LyrArc gist ›

1.5 Million Missing Black Men

11 Groups   
New York Times - 04.20.2015 Original article ›
Justin Wolfers, Justin, Wolfers, David Leonhardt, David, Leonhardt, Kevin Quealy, Kevin, Quealy

Heard on the Street - WSJ.com

1 Groups   
Wall Street Journal - 11.09.2006 Original article ›
Avery Johnson, Avery, Johnson, Anna Wilde Mathews, Anna, Wilde, Mathews
LyrArc Article Gist
Cuts in Medicare payments for drugs is feared by the pharmaceutical industry, as Democrats take control of Congress.
Read LyrArc gist ›

Generics Eat Into Pfizer's Profit; Costs Offset Novartis Sales Gain

1 Groups   
Wall Street Journal - 01.20.2006 Original article ›
Scott Hensley, Scott, Hensley, Anita Greil, Anita, Greil

As Generics Pummel Its Drugs, Pfizer Faces Uncertain Future

1 Groups   
Wall Street Journal - 01.05.2006 Original article ›
Scott Hensley, Scott, Hensley

Betting $10 Billion on Generics, Novartis Seeks to Inject Growth

1 Groups   
Wall Street Journal - 05.04.2006 Original article ›
Jeanne Whalen, Jeanne, Whalen

Selling Generic Drugs by Mail Turns Into Lucrative Business

1 Groups   
Wall Street Journal - 05.09.2006 Original article ›
Barbara Martinez, Barbara, Martinez

Zocor, Lipitor Feel Pinch from Generics

1 Groups   
Wall Street Journal - 07.14.2006 Original article ›
Scott Hensley, Scott, Hensley

Firms Prepare for a Fight Over Generic Drugs

1 Groups   
Wall Street Journal - 03.12.2009 Original article ›
Alicia Mundy, Alicia, Mundy

Generic Competition, Charges Hurt Glaxo's Net

1 Groups   
Wall Street Journal - 04.23.2009 Original article ›
Jeanne Whalen, Jeanne, Whalen, Elena Berton, Elena, Berton

Ranbaxy Unveils Its Ambition To Be a Generics Powerhouse

1 Groups   
Wall Street Journal - 01.10.2007 Original article ›
Nicholas Zamiska, Nicholas, Zamiska, Eric Bellman, Eric, Bellman

Pfizer Reports 18% Drop in Profit, Pares Outlook Amid Generics' Effect

1 Groups   
Wall Street Journal - 04.21.2007 Original article ›
Peter Loftus, Peter, Loftus

Drug Makers Tighten Their Belts Again

1 Groups   
Wall Street Journal - 07.27.2007 Original article ›
Peter Loftus, Peter, Loftus, Elena Berton, Elena, Berton
LyrArc Article Gist
How competition from generics and shortfall in new drugs and more consumer awareness of risks is affecting the sales of bigger drug companies
Read LyrArc gist ›

Generic May Test Sanofi, Bristol's Plavix in Europe

1 Groups   
Wall Street Journal - 05.10.2008 Original article ›
Jeanne Whalen, Jeanne, Whalen
LyrArc Article Gist
Schweizerhall to market generic version of Plavix in Europe with help of Sandoz, Novartis's generics company.
Read LyrArc gist ›

Generic-Drug Firm Actavis May Be Sold

1 Groups   
Wall Street Journal - 10.17.2008 Original article ›
Jeanne Whalen, Jeanne, Whalen

Generics hurt Sanofi sales

1 Groups   
Wall Street Journal - 11.01.2008 Original article ›

Teva to Acquire Ivax, Another Maker of Generic Drugs

2 Groups   
New York Times - 07.26.2005 Original article ›
Jennifer Bayot, Jennifer, Bayot

Merck Sets Deal That Prices Zocor Below New Generic

2 Groups   
Wall Street Journal - 06.21.2006 Original article ›
Heather Won Tesoriero, Heather, Won, Tesoriero, Barbara Martinez, Barbara, Martinez

Daiichi Targets Generics to Extend Reach

2 Groups   
Wall Street Journal - 06.12.2008 Original article ›
Hiroko Tabuchi, Hiroko, Tabuchi, Jackie Range, Jackie, Range

Teva to Buy U.S. Generic Rival Barr for $7.46 Billion

2 Groups   
Wall Street Journal - 07.19.2008 Original article ›
Shirley S. Wang, Shirley, S., Wang

Teva Deal Probe Gets Extension

2 Groups   
Wall Street Journal - 12.03.2008 Original article ›
Wsj Print, Wsj, Print
LyrArc Article Gist
Teva Pharmaceutical's acquisition of generic drug maker Barr Pharmaceutical for $7.46 billion to strengthen its position in emerging markets and expand its product portfolio.
Read LyrArc gist ›

Wyeth Loses Bout in Fight on a Generic

3 Groups   
New York Times - 09.08.2007 Original article ›
Stephanie Saul, Stephanie, Saul
LyrArc Article Gist
Protonix or Pantoprazole Wyeth's third best selling drug with sales of $1.8 billion has patent that expires in July 2010. Now a judge has ruled that Teva Pharmaceutical can introduce its generic version of this drug, Teva had filed a suit challenging the patent's validity and the judge ruled rejecting Wyeth's request to block the generic version from being marketed. Pantoprazole is used to treat severe inflammation of the esophagus from excess acid production.
Read LyrArc gist ›

Wyeth Hit by Generic Competition and Regulatory Setback

3 Groups   
New York Times - 12.25.2007 Original article ›
Bloomberg News, Bloomberg, News
LyrArc Article Gist
Generics from Teva Pharmaceuticals hurt Wyeth as Teva starts a generic for Protonix a heartburn medicine.
Read LyrArc gist ›

Branded Drugs Settling More Generic Suits

2 Groups   
Wall Street Journal - 01.17.2006 Original article ›
Leila Abboud, Leila, Abboud

Support LyrArc

We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.

Support Lyrarc from as small as $1




Support LyrArc →


Copyright © 2006 - 2026 Intelilinks LLC
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us